Plain English Summary
Background and study aims
Diabetes is a life-long condition where a person is unable to control their blood sugar levels. An important part of diabetes management is maintaining a healthy lifestyle, namely eating well, exercising and taking medication properly. Digital interventions (programs) are an effective tool for health promotion and helping people to manage long-term conditions. However, their effectiveness is limited by low usage rates, with non-engagement posing a major challenge. Technological prompts (e.g. emails) are one method of encouraging people to better engage with the material, however the specific effect of their characteristics (e.g. delivery mode, content) on engagement has not previously been thoroughly investigated. This will be investigated in two similar studies, which test different content and delivery modes on promoting engagement with a digital intervention called HeLP-Diabetes. HeLP-Diabetes is a digital intervention that aims to promote self-management among people with diabetes.
Who can participate?
In the first study, registered users of HeLP-Diabetes who have subscribed to email prompts are able to take part. In the second study, registered users of HeLP-Diabetes who have subscribed to email and text message prompts are able to take part.
What does the study involve?
In the first study, participants are randomly allocated to one of two groups. Participants in the first group receive an email containing and email prompt with news and updates. This includes a new research article about how diabetes education programmes can help patients lower their blood sugar as well as links of videos of people discussing how diabetes brought some positive changes into their lives and reminders and tips on how to help control Type 2 Diabetes more easily. Participants in the second group receive the email prompt without news and updates, which includes the video links and reminders and tips only. Over the next five days, the number of participants in both groups who visited the HeLP-Diabetes website and those who opened the email prompt are recorded.
In the second study, participants are randomly allocated to one of two groups. Participants in the first group receive an email containing a link to a specific webpage. Those in the second group receive a text message prompt containing a link to a specific webpage. Over the next five days, the number of participants in both groups who visited the HeLP-Diabetes website are recorded.
What are the possible benefits and risks of participating?
Participants can benefit from the content of the prompts they receive, as the information can help them to better control their diabetes. There are no major risks involved with participating, although some participants may not like the content of the prompts or feel annoyed by them.
Where is the study run from?
The study is run from University College London and takes place on the internet (UK)
When is the study starting and how long is it expected to run for?
September 2015 to April 2016
Who is funding the study?
1. Saudi Arabian Cultural Bureau in London (UK)
2. HeLP-Diabetes was funded by National Institute for Health Research (UK)
Who is the main contact?
Mrs Ghadah Alkhadi
Trial website
Contact information
Type
Public
Primary contact
Mrs Ghadah Alkhaldi
ORCID ID
http://orcid.org/0000-0001-9041-4546
Contact details
e-Health Unit
UCL Research Department of Primary Care & Population Health
Upper 3rd Floor
Royal Free Campus
Rowland Hill Street
London
NW3 2PF
United Kingdom
+44 20 7794 0500 (ext: 31399)
ghadah.alkhaldi.12@ucl.ac.uk
Additional identifiers
EudraCT number
ClinicalTrials.gov number
Protocol/serial number
1.1
Study information
Scientific title
Testing content and delivery modes of HeLP-Diabetes prompts on user visits: two pilot randomised controlled trials
Acronym
Study hypothesis
Trial 1:
Email prompt with news and updates will be associated with a higher proportion of participants visiting the digital intervention(HeLP-Diabetes) compared to an email prompt that does not have news and updates.
Trial 2:
The use of an email prompt will be associated with a higher proportion of participants visiting the digital intervention (HeLP-Diabetes) compared to the use of a text message prompt.
Ethics approval
The email and text message prompts were included as a part of the HeLP-Diabetes website intervention that was developed following the results of this study (Development, evaluation and implementation of a computer- based self-management programme for people with Type 2 Diabetes, REC reference: North West London Research Ethics Committee, 10/01/2011, ref: 10/H0722/86). Users who were registered to use the HeLP-Diabetes programme had actively agreed to the original Terms and Conditions when signing up to receive prompts via emails and text messages as part of the intervention and that their usage data including website visits would be stored anonymously and used for analysis.
As no new users were recruited, it was advised that ethical approval for this study was not required as no participant was actively recruited for this study, only participants who had been using the website before the start of this study and who subscribed to emails and text messages were enrolled.
Study design
Two sequential randomised two-arm pilot trials
Primary study design
Interventional
Secondary study design
Randomised controlled trial
Trial setting
Internet
Trial type
Other
Patient information sheet
No specific participant information sheet available, please use the contact details below to request a further information.
Condition
Diabetes mellius
Intervention
Randomisation for both Trial 1 and 2:
Randomisation was done by extracting only user identification numbers from the HeLP-Diabetes database then using the website (https://www.random.org/), to generate two lists of randomised identification numbers. Each list was then halved, resulting in four groups: two for Trial 1 and two for Trial 2. After getting the randomised list of user identification numbers for all the groups, SoftForge (i.e. the developers of HeLP-Diabetes) built the four groups into the HeLP-Diabetes system.
Trial 1:
Arm 1: At baseline (19/10/2015), participants receive an email prompt with news and updates. This includes a new research article about how diabetes education programmes can help patients to decrease their blood glucose level, as well as a link to videos of people discussing how diabetes brought some positive changes into their lives and reminders and tips on how to help control Type 2 Diabetes more easily.
Arm 2: At baseline (19/10/2015), participants receive an email prompt without news and updates. This includes a link to videos of people discussing how diabetes brought some positive changes into their lives and reminders and tips on how to help control Type 2 Diabetes more easily.
Participants in both groups are followed up for five days
Trial 2:
Arm 1: At baseline (26/10/2015), participants receive an email prompt that contained a link to a specific webpage, for example, a link to a sugar-free recipe.
Arm 2: At baseline (26/10/2015), participants receive a text message prompt that contained a link to a specific webpage (the same link as provided to the group receiving the email).
Participants in both groups are followed up for five days
Intervention type
Behavioural
Phase
Drug names
Primary outcome measures
Trial 1 and 2:
Proportion of participants who visited HeLP-Diabetes at least once after receiving prompts during a period of 5 days is measured objectively through HeLP-Diabetes.
Secondary outcome measures
Trial 1:
Proportion of participants who opened an email prompt at least once up to 5 days after receiving Trial 1 email prompts is measured objectively through HeLP-Diabetes.
Overall trial start date
30/09/2015
Overall trial end date
30/04/2016
Reason abandoned
Eligibility
Participant inclusion criteria
Trial 1 :
1. Registered users of HeLP-Diabetes
2. Subscribers to email prompts
Trial 2:
1. Registered users of Help-Diabetes who provided cell phone numbers and agreed to receive text message prompts
2. Subscribers to email prompts
3. Included in trial 1
Participant type
Patient
Age group
Adult
Gender
Both
Target number of participants
279
Participant exclusion criteria
Trial 1 and 2:
1. Users registered after 30 September 2015 (as anyone who registered after this date would not have received an email or a text message prompt until the intervention period)
2. Users registered on HeLP-Diabetes randomised controlled trial plan (as this group of users cannot be randomised to receive different prompts until the end of the trial in early 2016)
Recruitment start date
30/09/2015
Recruitment end date
05/10/2015
Locations
Countries of recruitment
United Kingdom
Trial participating centre
University College London
Royal Free Campus
Rowland Hill Street
London
NW3 2PF
United Kingdom
Funders
Funder type
Government
Funder name
Saudi Arabian Cultural Bureau in London
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Funder name
HeLP-Diabetes was funded by National Institute for Health Research
Alternative name(s)
Funding Body Type
Funding Body Subtype
Location
Results and Publications
Publication and dissemination plan
Planned publication in a peer reviewed journal.
Intention to publish date
30/04/2017
Participant level data
Available on request
Results - basic reporting
Publication summary